Cargando…

Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments

INTRODUCTION: The purpose of this study was to quantify United States (US) and United Kingdom (UK) physicians’ preferences for attributes of type 2 diabetes treatments. METHODS: Samples of general practitioners (GPs) and endocrinologists in the US (n = 204) and the UK (n = 200) completed a discrete-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulos, Christine, González, Juan Marcos, Lee, Lauren J., Boye, Kristin S., Johnson, F. Reed, Bae, Jay P., Deeg, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889326/ https://www.ncbi.nlm.nih.gov/pubmed/24254337 http://dx.doi.org/10.1007/s13300-013-0046-7

Ejemplares similares

Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain
por: Yurgin, Nicole Rae, et al.
Publicado: (2008)

Chronotype preference and glycemic control in type 2 diabetes
por: Xue, Pei, et al.
Publicado: (2021)

Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study
por: Poulos, Christine, et al.
Publicado: (2020)

Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
por: Rhee, Eun-Jung
Publicado: (2022)

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)
por: Zenari, Luciano, et al.
Publicado: (2020)

Family Physician Clinical Inertia in Glycemic Control among Patients with Type 2 Diabetes
por: Lang, Valerija Bralić, et al.
Publicado: (2015)

Health Literacy, Glycemic Control, and Physician-Advised Glucose Self-Monitoring Use in Type 2 Diabetes
por: Alvarez, Paul M., et al.
Publicado: (2018)

Clinical audit on assessment of non-glycemic parameters in diabetic patients by physicians
por: Ramya, S, et al.
Publicado: (2021)

Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey
por: Mansfield, Carol, et al.
Publicado: (2017)

National physician survey on glycemic goals and medical decision making for patients with type 2 diabetes
por: Laiteerapong, Neda, et al.
Publicado: (2019)

Extra dimensions prefer large $\tan\beta$
por: Kubo, J, et al.
Publicado: (2000)

Patient Preference and Satisfaction with the Use of Telemedicine for Glycemic Control in Patients with Type 2 Diabetes: A Review
por: Sim, Ruth, et al.
Publicado: (2021)

Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
por: Alghadeer, Sultan M., et al.
Publicado: (2021)

Patient Preference for Physician Gender in the Emergency Department
por: Nolen, Haley A., et al.
Publicado: (2016)

Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
por: González, Juan Marcos, et al.
Publicado: (2017)

Preferred practice pattern of physicians regarding diabetic retinopathy in diabetes mellitus patients
por: Moudgil, Tania, et al.
Publicado: (2021)

Effect of COVID 19 Lockdown on glycemic parameters in people with type 2 diabetes
por: Tewari, Ajoy, et al.
Publicado: (2021)

Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study
por: Reed, Shelby D., et al.
Publicado: (2021)

Social preferences of future physicians
por: Li, Jing, et al.
Publicado: (2017)

The Influence of Physician-Rating Websites on Patient Physician Preference
por: Malige, Ajith, et al.
Publicado: (2020)

The impact of adding an extra dimension to a preference-based measure
por: Brazier, John, et al.
Publicado: (2011)

Type 2 diabetes pharmacotherapy trends in high‐risk subgroups
por: Bae, Jay, et al.
Publicado: (2022)

Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
por: Eckel, Robert H., et al.
Publicado: (2015)

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE
por: Poulos, Christine, et al.
Publicado: (2018)

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment
por: Okumura, Ken, et al.
Publicado: (2015)

Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE
por: Bell, Christopher F., et al.
Publicado: (2020)

Validity and analysis of the Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Boye, Kristina S., et al.
Publicado: (2020)

06. United States Healthcare Provider Preferences for Adult Pneumococcal Vaccine Recommendations
por: Vietri, Jeffrey, et al.
Publicado: (2021)

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
por: Smith-Palmer, Jayne, et al.
Publicado: (2016)

Adaptation of the WOMAC for Use in a Patient Preference Study
por: Stothers Rosenberg, Sarah, et al.
Publicado: (2023)

Observational study evaluating the effectiveness of physician‐targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II)
por: Weng, Jianping, et al.
Publicado: (2019)

Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments
por: Boye, Kristina S., et al.
Publicado: (2021)

Quality of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus
por: Holmer, Haley K., et al.
Publicado: (2013)

Physicians' Preferences for Asthma Guidelines Implementation
por: Kang, Min-Koo, et al.
Publicado: (2010)

Preferred Provider Organizations and Physician Fees
por: Verrilli, Diana K., et al.
Publicado: (1996)

Experimental evidence of physician social preferences
por: Li, Jing, et al.
Publicado: (2022)

Managing Type 2 Diabetes: Going Beyond Glycemic Control
por: Stolar, Mark W., et al.
Publicado: (2008)

Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes
por: Lederle, Lauren I., et al.
Publicado: (2022)

Depression, glycemic control and type 2 diabetes
por: Papelbaum, Marcelo, et al.
Publicado: (2011)

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
por: Fu, Haoda, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_38v3257po1kqmosjpnkfi1bkj1